Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report.

  title={Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report.},
  author={Alexander J. Kallen and Steven Woloshin and Jennifer Shu and Ellen Juhl and Lisa M. Schwartz},
  journal={Health affairs},
  volume={26 5},
Direct-to-consumer (DTC) prescription drug advertisements for HIV anti-retrovirals are controversial and have been criticized in the past for including deceptive images and underplaying HIV drug limitations. We sought to describe the state of recent DTC ads for HIV antiretrovirals in popular magazines by performing a content analysis of all complete DTC ads for antiretroviral medications appearing in eight national magazines during a one-year period. Current ads appear to have addressed… 
A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
To minimize potential harm and maximize the benefits of DTCA for population health, the quality and quantity of information should be improved to enable consumers to better self- identify whether treatment is indicated, more realistically appraise the benefits, and better attend to the risks associated with prescription drugs.
Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale
Although DTCA spending per capita is much lower in Canada than in the US, there is no evidence of safer content or product choice; many heavily-advertised drugs in Canada have been subject to safety advisories.
Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials
These randomized trials tested whether adding a drug facts box to consumer prescription advertisements improved consumer knowledge and judgment and helped consumers choose the superior drug.
Enhancing the educational value of direct-to-consumer advertising of prescription drugs.
  • M. Hwang, H. Young
  • Education
    Journal of the American Pharmacists Association : JAPhA
  • 2017
Ethical and epistemic issues in direct-to-consumer drug advertising: where is patient agency?
Recent research is examined on ways in which patients are vulnerable with respect to direct-to-consumer drug advertising and the focus should not be simply on what information patients need in order to make medical decisions, but also on the conditions under which patients actually are able to makemedical decisions requiring complex medication information.
HIV/AIDS Complacency and HIV Infection Among Young Men Who Have Sex With Men, and the Race-Specific Influence of Underlying HAART Beliefs
Programs that target HIV/AIDS complacency as a means to reduce HIV incidence among young MSM should consider that both the prevalence of strong HAART-efficacy beliefs and the effects of these beliefs on HIV-infection risk might differ considerably by race/ethnicity.
Beyond Content Analysis: Assessing Fair Balance in DTC Pharmaceutical Advertising
An advertisement is considered to provide fair balance when its presentation of drug risks and benefits is re...
Social relationships and social anxiety appeals in direct-to-consumer advertising
Abstract The use of social relationships as a promotional tool in direct-to-consumer (DTC) advertising has received limited attention despite relational impacts on illnesses and empirical evidence


FDA warning to manufacturers of AIDS drugs.
  • D. Josefson
  • Medicine
    The Western journal of medicine
  • 2001
Preliminary evidence supports the contention that the drug companies' advertisements may alter behavior by their overly optimistic message, and the FDA's decision may lead to closer scrutiny of “direct-to-consumer” drug advertising.
The value of benefit data in direct-to-consumer drug ads.
An evaluation of a "prescription drug benefit box"-data from the main randomized trials on the chances of various outcomes with and without the drug.
Are HIV drug advertisements contributing to increases in risk behavior among men in San Francisco, 2001?
It was found that homosexual men frequently saw HIV medication advertisements and believed HIV was a less serious disease, and men believed these advertisements influenced an individual's decision to have unprotected sex.
A Closer Look at the Concept, Historical Overview, and Value of Direct-to-Consumer Advertising of Prescription Drugs
The informational aspect of advertising is the main defense of pharmaceutical companies toward their direct-to-consumer advertising expenditures, and critics are skeptical of the ability of television advertisement to provide accurate information to consumers about the advertised drug.
FDA considers tightening regulations for direct-to-consumer advertising.
  • B. Vastag
  • Medicine, Business
    Journal of the National Cancer Institute
  • 2005
Social scientists and other observers remain divided over the impact on consumer behavior of direct-to-consumer drug advertising for pharmaceuticals, which appeared as print advertisements in the mid-1980s and on radio and TV in 1997.
Timing of new black box warnings and withdrawals for prescription medications.
To determine the frequency and timing of discovery of new ADRs described in black box warnings or necessitating withdrawal of the drug from the market, Examination of the Physicians' Desk Reference for all new chemical entities approved by the US Food and Drug Administration between 1975 and 1999 is examined.
The measurement of observer agreement for categorical data.
A general statistical methodology for the analysis of multivariate categorical data arising from observer reliability studies is presented and tests for interobserver bias are presented in terms of first-order marginal homogeneity and measures of interob server agreement are developed as generalized kappa-type statistics.
Untitled letter from the FDA re
  • Viramune (nevirapine),
  • 2004
FDA examines direct-to-consumer advertising data.
  • D. Young
  • Business
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2003